SMIM2
gene geneOn this page
Also known as MGC5590
Summary
SMIM2 (small integral membrane protein 2, HGNC:28776) is a protein-coding gene on chromosome 13q14.11, encoding Small integral membrane protein 2 (Q9BVW6).
Predicted to be located in membrane.
Source: NCBI Gene 79024 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 1 total
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28776 |
| Approved symbol | SMIM2 |
| Name | small integral membrane protein 2 |
| Location | 13q14.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC5590 |
| Ensembl gene | ENSG00000139656 |
| Entrez | 79024 |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Bgee: expression breadth ubiquitous, 142 present calls, max score 90.55.
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 90.55 | gold quality |
| right testis | UBERON:0004534 | 90.23 | gold quality |
| testis | UBERON:0000473 | 85.71 | gold quality |
| sperm | CL:0000019 | 77.29 | gold quality |
| male germ cell | CL:0000015 | 75.05 | gold quality |
| buccal mucosa cell | CL:0002336 | 68.18 | gold quality |
| right coronary artery | UBERON:0001625 | 58.45 | gold quality |
| mucosa of stomach | UBERON:0001199 | 58.03 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 55.06 | gold quality |
| pancreatic ductal cell | CL:0002079 | 54.11 | silver quality |
| popliteal artery | UBERON:0002250 | 53.77 | gold quality |
| tibial artery | UBERON:0007610 | 53.76 | gold quality |
| islet of Langerhans | UBERON:0000006 | 53.25 | gold quality |
| cartilage tissue | UBERON:0002418 | 52.92 | gold quality |
| rectum | UBERON:0001052 | 52.37 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 52.09 | gold quality |
| transverse colon | UBERON:0001157 | 51.36 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 50.95 | gold quality |
| metanephros cortex | UBERON:0010533 | 50.69 | gold quality |
| metanephros | UBERON:0000081 | 50.41 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 50.18 | gold quality |
| small intestine | UBERON:0002108 | 49.73 | gold quality |
| coronary artery | UBERON:0001621 | 49.41 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| left coronary artery | UBERON:0001626 | 49.18 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
| muscle tissue | UBERON:0002385 | 49.17 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.79 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Small integral membrane protein 2 — Q9BVW6 (reviewed: Q9BVW6)
All UniProt accessions (0):
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
UniProt features (3 total): chain 1, transmembrane region 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BVW6-F1 | 67.00 | 0.02 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
78 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SMIM2 | SMIM1 | B2RUZ4 | 446 |
| SMIM2 | SMIM3 | Q9BZL3 | 418 |
| SMIM2 | GAL3ST4 | Q96RP7 | 400 |
| SMIM2 | UBXN11 | Q5T124 | 370 |
| SMIM2 | MACIR | Q96GV9 | 366 |
| SMIM2 | INTS1 | Q8N201 | 366 |
| SMIM2 | DNAAF5 | Q86Y56 | 348 |
| SMIM2 | ANKRD55 | Q3KP44 | 317 |
| SMIM2 | CLYBL | Q8N0X4 | 317 |
| SMIM2 | BBX | Q8WY36 | 307 |
| SMIM2 | RAI14 | Q9P0K7 | 303 |
| SMIM2 | BLCAP | P62952 | 271 |
| SMIM2 | RNASET2 | O00584 | 260 |
| SMIM2 | ST3GAL3 | Q11203 | 257 |
| SMIM2 | ST3GAL6 | Q9Y274 | 257 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| UBQLN1 | SMIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMIM2 | UBQLN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMIM2 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMIM2 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): SMIM2 (Two-hybrid), UBQLN2 (Two-hybrid)
ESM2 similar proteins: A0A1B0GUQ0, A0A1B0GV22, A4WGH3, A5WBB8, A8A6G6, B1IX34, B1X9T3, B5BIL7, B5QUQ3, B5RFY4, B7L848, B7LK47, B7M557, B7MGC6, B7N2F0, B7NF22, B7NR07, B8MYS5, C0Q2L2, C4ZYY2, O71190, O83770, P03167, P03168, P05443, P0A8C8, P0A8C9, P0C304, P0C305, P12173, P12478, P20464, P53231, P61468, P61472, Q16612, Q1R4N0, Q31UV8, Q329B3, Q3SSW2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000076053 (13:44162683 C>T), RS1000232448 (13:44162319 A>T), RS1000463019 (13:44155442 T>C), RS1000797890 (13:44150470 C>A,G), RS1000829921 (13:44159899 C>G), RS1000897021 (13:44160362 C>G,T), RS1001007641 (13:44152635 T>A), RS1001062158 (13:44145427 A>G), RS1001234251 (13:44162175 G>T), RS1001350159 (13:44157266 C>T), RS1001737581 (13:44159479 C>A), RS1002011720 (13:44150053 C>T), RS1002127726 (13:44149733 C>T), RS1002379611 (13:44146691 C>T), RS1002632758 (13:44153427 G>A,C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004505_105 | Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) | 1.000000e-08 |
| GCST004508_26 | Waist-to-hip ratio adjusted for BMI in non-smokers | 3.000000e-10 |
| GCST004858_16 | Dupuytren’s disease | 2.000000e-10 |
| GCST007401_20 | Factor VII activity | 2.000000e-06 |
| GCST011769_5 | Schizophrenia | 1.000000e-08 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004318 | smoking behavior |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0004229 | Dupuytren Contracture |
| EFO:0004619 | factor VII measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression, affects cotreatment | 1 |
| Cadmium | increases abundance, decreases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Lipopolysaccharides | affects response to substance, increases expression, affects cotreatment | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.